86 related articles for article (PubMed ID: 18420394)
1. Prevalence of overt metastases in locally advanced breast cancer.
Al-Husaini H; Amir E; Fitzgerald B; Wright F; Dent R; Fralick J; Clemons M
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):340-4. PubMed ID: 18420394
[TBL] [Abstract][Full Text] [Related]
2. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation.
Schneider C; Fehr MK; Steiner RA; Hagen D; Haller U; Fink D
Arch Gynecol Obstet; 2003 Nov; 269(1):9-12. PubMed ID: 14605816
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
4. Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice?
Kosmider S; Stella DL; Field K; Moore M; Ananda S; Oakman C; Singh M; Gibbs P
Colorectal Dis; 2009 Jul; 11(6):592-600. PubMed ID: 18624816
[TBL] [Abstract][Full Text] [Related]
5. Staging procedures in primary breast cancer.
Müller D; Köhler G; Ohlinger R
Anticancer Res; 2008; 28(4C):2397-400. PubMed ID: 18751425
[TBL] [Abstract][Full Text] [Related]
6. Baseline staging of newly diagnosed breast cancer--Kuwait cancer control center experience.
Abuzallouf S; Motawy M; Thotathil Z
Med Princ Pract; 2007; 16(1):22-4. PubMed ID: 17159359
[TBL] [Abstract][Full Text] [Related]
7. Is locally advanced breast cancer a neglected disease?
Akhtar M; Akulwar V; Gandhi D; Chandak K
Indian J Cancer; 2011; 48(4):403-5. PubMed ID: 22293251
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic strategies for pre-treatment staging of patients with oesophageal cancer.
van Heijl M; Omloo JM; van Berge Henegouwen MI; Smits NJ; Phoa SS; Bergman JJ; Sloof GW; van Lanschot JJ; Bossuyt PM
Dig Surg; 2009; 26(2):149-55. PubMed ID: 19342861
[TBL] [Abstract][Full Text] [Related]
10. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
[TBL] [Abstract][Full Text] [Related]
11. Pattern of care in locally advanced breast cancer: focus on local therapy.
Sinacki M; Badzio A; Wełnicka-Jaśkiewicz M; Bogaerts J; Piccart MJ; Therasse P; Smith IE; Hatschek T; Jassem J
Breast; 2011 Apr; 20(2):145-50. PubMed ID: 20870406
[TBL] [Abstract][Full Text] [Related]
12. The role of large core needle biopsy in locally advanced breast cancer.
Pace ME; Berg WA
Md Med J; 1997 Sep; 46(8):419-23. PubMed ID: 9294949
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancer.
Renz DM; Baltzer PA; Böttcher J; Thaher F; Gajda M; Camara O; Runnebaum IB; Kaiser WA
Acad Radiol; 2008 Feb; 15(2):209-21. PubMed ID: 18206620
[TBL] [Abstract][Full Text] [Related]
16. [Cost-benefit in the study of the dissemination of stage I and II in breast cancer].
Camacho J; Barriga C; Escobar P; Seleme N; Schwartz R
Rev Med Chil; 2003 Feb; 131(2):155-7. PubMed ID: 12708253
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
18. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
[TBL] [Abstract][Full Text] [Related]
20. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer.
Mameri CS; Kemp C; Goldman SM; Sobral LA; Ajzen S
Breast J; 2008; 14(3):236-44. PubMed ID: 18476882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
